Home

Tuesday, 2 September 2025

Bioelectronic Skin Patches Market Size & Share Report, 2030

 

Bioelectronic Skin Patches Market Trends

The global bioelectronic skin patches market size was valued at USD 6.1 billion in 2024 and is projected to grow at a CAGR of 10.76% from 2025 to 2030. The growth can be attributed to the rising chronic diseases, technological advancements, growing health awareness, aging population, and significant investment in R&D. Chronic diseases such as diabetes, cancer, asthma, Alzheimer's disease, Parkinson's disease, and others often require frequent injections, and bioelectronic skin patches offer a convenient and manageable solution. According to the World Health Organization (WHO), the global prevalence of diabetes reached around 830 million in 2022, with significantly higher prevalence in lower- and middle-income countries.

The rising prevalence of chronic diseases globally is a key factor expected to drive market growth. Factors such as antimicrobial resistance, unhealthy & sedentary lifestyles, and tobacco & alcohol consumption are contributing to the rising prevalence of Noncommunicable Diseases (NCDs). For instance, CDC data published in July 2022 estimated that nearly 6 in 10 adults in the U.S. were diagnosed with chronic diseases, such as cancer, heart disease, or diabetes. Chronic diseases, including heart disease, cancer, and diabetes, are the leading causes of death & disability in the U.S., accounting for around USD 4.1 trillion in annual healthcare costs.

Advancements in wearable technology are significantly accelerating the bioelectronic skin patches industry by enhancing sensory feedback, energy efficiency, and real-time health monitoring capabilities. Recent breakthroughs in bioelectronics from institutions like Northwestern University and the University of Missouri are paving the way for transformative applications in healthcare and beyond. In November 2024, a Northwestern University-led team unveiled a new type of wearable device that stimulates the skin to deliver complex sensations. This thin, flexible device adheres to the skin, providing immersive sensory experiences. While its applications extend to gaming and virtual reality (VR), it holds great promise for healthcare, particularly for individuals with visual impairments and prosthetic limb users.

Similarly, researchers at the University of Missouri in April 2024, led by Zheng Yan, recently introduced a groundbreaking bioelectronic wearable with wireless charging capabilities, eliminating the need for batteries. Detailed in Nature Nanotechnology, this innovation provides a stable electrical connection through an ultrasoft, breathable, and stretchable material. Unlike traditional rigid wearables, the device maintains accurate real-time health monitoring, including vital signs such as blood pressure and electrical heart activity. This advancement paves the way for long-term self-health monitoring and early disease detection, with potential applications in managing chronic conditions like heart disease, diabetes, and cancer.

Market Concentration & Characteristics

The industry is characterized by innovations in materials and design, as well as advancements in sensor technology. These patches enable continuous monitoring of vital signs and glucose levels and are increasingly used for fitness tracking, stress monitoring, and general wellness, thereby catering to a broad range of consumer needs.

The market exhibits a moderate degree of innovation. Advances in sensor technology have enabled the development of highly sensitive sensors that can detect minute changes in physiological parameters, such as glucose, pH levels, and electrolytes. For instance, in April 2023, MIT researchers created a wearable patch that uses painless ultrasonic waves to create tiny channels in the skin for drug delivery. This technology could be used for treating various skin conditions and administering hormones, muscle relaxants, and other medications.

Type Insights

The electrochemical sensors segment accounted for the largest revenue share of 36.2% in 2024 and is expected to witness the fastest growth at a CAGR of 12.64% over the forecast period. Electrochemical sensors play a crucial role in the market, enabling real-time, noninvasive monitoring of biochemical markers with high sensitivity. These sensors detect analytes like glucose, lactate, and pH levels by measuring electrical currents generated through interactions with chemical components, ensuring continuous health tracking. A recent study published in Microsystems & Nanoengineering in January 2023 highlights advancements in wearable and flexible electrochemical sensors for sweat analysis. These sensors are essential in personalized health monitoring due to their cost-effectiveness, miniaturization, and versatility. Soft microfluidics, multiplexed biosensing, and self-powered devices have further improved their functionality.

Application Insights

The medical monitoring segment accounted for the largest market share in 2024. Medical monitoring is a key application in the industry, offering continuous, non-invasive tracking of vital health parameters. A major breakthrough occurred in June 2024, when researchers at the University of Missouri developed a soft, self-charging, battery-free bioelectronic device with wireless charging capabilities. This breathable, stretchable material enables precise monitoring of blood pressure, electrical heart activity, and skin hydration, improving early disease detection and intervention for conditions such as heart disease, cancer, and diabetes.

Regional Insights

North America bioelectronic skin patches market dominated the global industry and accounted for 41.87% revenue share in 2024, driven by advancements in wearable health technology, increasing prevalence of chronic diseases, and growing consumer demand for remote health monitoring solutions. These patches, which integrate flexible electronics with biocompatible materials, offer real-time tracking of physiological parameters such as glucose levels, heart rate, temperature and others. The rising adoption of telehealth and digital health platforms has further accelerated their demand, particularly among patients managing conditions like diabetes, cardiovascular diseases, and neurological disorders.

Global Bioelectronic Skin Patches Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global bioelectronic skin patches market report on the basis of type, application, end-use and region:

Medical Device Clinical Trials Market To Reach $23.53 Billion By 2030

 

Medical Device Clinical Trials Market Growth & Trends

The global medical device clinical trials market size is expected to reach USD 23.53 billion by 2030, and is anticipated to grow at a CAGR of 6.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by a rising number of clinical trials, growing R&D investments, and regulatory requirements for device validation. In addition, constant technological advancements, such as AI-driven analytics, automation, and digital platforms, are revolutionizing trial efficiency by optimizing patient recruitment, real-time monitoring, and data analysis. The integration of machine learning, decentralized trial models, and wearable technology is further enhancing trial accuracy and reducing costs.

Moreover, the increasing integration of wearable devices and digital biomarkers in clinical trials has significantly transformed patient monitoring and data collection by enabling continuous, real-world health tracking. Devices such as smartwatches, biosensors, and remote health trackers provided real-time physiological data, allowing researchers to monitor patients outside of clinical settings, which enhanced trial accuracy and reduced the need for frequent site visits. This advancement has driven the widespread adoption of decentralized and hybrid clinical trials, enabling greater patient participation, particularly among those in remote or underserved areas.

Furthermore, the shift toward personalized medicine and patient-specific treatment approaches has significantly driven the demand for customized medical devices, particularly in fields such as orthopedics, cardiology, and oncology. The growing emphasis on tailored therapies had necessitated the development of medical devices designed to meet individual patient needs, leading to increased clinical trials focused on adaptive study designs. These trials allowed for real-time modifications based on patient-specific responses, ensuring more precise, effective, and safer outcomes. With advancements in 3D printing, AI-driven diagnostics, and biomaterial engineering, medical device manufacturers have expanded their capabilities to create highly personalized implants, prosthetics, and drug-device combinations.

Key market players are implementing strategic partnerships, product innovations, regulatory approvals, geographic expansions, and AI-driven trial solutions to strengthen their position in the Medical Device Clinical Trials market. Companies like Medtronic and Siemens Healthineers have expanded their AI-driven clinical trial ecosystems, while Abbott secured FDA approval for a label update on its HeartMate 3 LVAD to enhance patient management.

 Request a free sample copy or view report summary:
Medical Device Clinical Trials Market Report

Medical Device Clinical Trials Market Report Highlights

Medical Device Clinical Trials Market Segmentation

Grand View Research has segmented the global medical device clinical trials market based on study type, study design, indication, and region:

Medical Device Clinical Trials Study Type Outlook (Revenue, USD Million, 2018 - 2030)

Medical Device Clinical Trials Study Design Outlook (Revenue, USD Million, 2018 - 2030)

Medical Device Clinical Trials Indication Outlook (Revenue, USD Million, 2018 - 2030)


Acute Myeloid Leukemia Treatment Market Size Report, 2030

 

Acute Myeloid Leukemia Treatment Market Summary

The global acute myeloid leukemia treatment market size was estimated at USD 3.47 billion in 2024 and is projected to reach USD 6.29 billion by 2030, growing at a CAGR of 10.6% from 2025 to 2030. The increasing geriatric population base and growing unmet healthcare needs are expected to boost market growth further.

Key Market Trends & Insights

Market Size & Forecast


Rising incidences of acute myeloid leukemia and increasing need for advanced therapeutics are attributed to factors such as genetic mutations, unhealthy lifestyles, continued exposure to hazardous chemicals such as benzene, and radiation exposure.

Advancements in targeted therapies have been at the forefront of the progress in Acute Myeloid Leukemia (AML) treatment so far. In recent years, there has been substantial development in therapies such as BCL2 inhibitors, IDH inhibitors, and FLT3 inhibitors. These therapies provide personalized treatment options tailored to specific genetic mutations, resulting in improved outcomes for patients. For instance, in July 2023, the FDA approved quizartinib (Vanflyta) for newly diagnosed FLT3-ITD positive acute myeloid leukemia in the U.S., enhancing treatment options alongside standard chemotherapy.

Global Acute Myeloid Leukemia Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global acute myeloid leukemia treatment market report based on disease, treatment, route of administration, end use, and region:

Subscribe to: Posts (Atom)